More Imugene Ltd news Imugene LtdASX: IMU Dose escalates In Phase I Clinical Trial of New Oncolytic Vi Nov 11, 2022 at 5:25 AM UTC · Issued by Imugene Ltd As issuedPlain English Imugene Ltd has released a press release. View Attachment
